Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection-Reference-Cited by-同舟云学术

Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection

Published:2010-07-14 Issue:2 Volume:102 Page:111-118
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Ashikaga Takamaru,Krag David N.,Land Stephanie R.,Julian Thomas B.,Anderson Stewart J.,Brown Ann M.,Skelly Joan M.,Harlow Seth P.,Weaver Donald L.,Mamounas Eleftherios P.,Costantino Joseph P.,Wolmark Norman

Funder

National Cancer Institute, Department of Health and Human Services, Public Health Service

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.21535/fullpdf

Reference14 articles.

1. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): A randomized controlled surgical trial;Gill;Ann Surg Oncol,2009

2. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: Results of the sentinella-GIVOM Italian randomised clinical trial;Del Bianco;Eur J Surg Oncol,2008

3. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial;Mansel;J Natl Cancer Inst,2006

4. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer;Fleissig;Breast Cancer Res Treat,2006

5. Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial;Purushotham;J Clin Oncol,2005

Cited by 402 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualized prediction of non-sentinel lymph node metastasis in Chinese breast cancer patients with ≥ 3 positive sentinel lymph nodes based on machine-learning algorithms;BMC Cancer;2024-09-02

2. Prevention and Treatment of Lymphedema in Breast Cancer;Advances in Surgery;2024-09

3. Omitting Axillary Lymph Node Dissection Is Associated With an Increased Risk of Regional Recurrence in Early Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials;Clinical Breast Cancer;2024-08

4. Omission of Completion Axillary Lymph Node Dissection for Patients with Breast Cancer Treated by Upfront Mastectomy and Sentinel Node Isolated Tumor Cells or Micrometastases;Cancers;2024-07-26

5. A two-center study of a combined nomogram based on mammography and MRI to predict ALN metastasis in breast cancer;Magnetic Resonance Imaging;2024-07